US Patent
US8383659 — Isoxazoline derivatives as pesticides
Composition of Matter · Assigned to Novartis AG · Expires 2030-01-17 · 4y remaining
Vulnerability score
18/100
Ironclad — strong claim type, well-established, deep family
What this patent protects
This patent protects novel isoxazoline compounds with pesticidal properties for use on non-human animals.
USPTO Abstract
Novel isoxazoline compounds and compositions containing the compounds are disclosed. The compounds have pesticidal properties and are suitable for use on non-human animals.
Drugs covered by this patent
- Xdemvy (LOTILANER) · Tarsus
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.